Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000905148-26-000894·Alto Neuroscience, Inc.
Schedule 13G ownership disclosure
Alto Neuroscience Inc
Common Stock, $0.0001 par value per share · CUSIP: 02157Q109
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- K2 HealthVentures Equity Trust LLC
Shares: 788,995 · Class: 2.4%
- Parag Shah
Shares: 788,995 · Class: 2.4%
- Anup Arora
Shares: 788,995 · Class: 2.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905148-26-000894
- Form type
- SCHEDULE 13G/A
- Filer
- Alto Neuroscience, Inc.
- CIK
- CIK 1999480
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership